New therapeutic targets in the management of urothelial carcinoma of the bladder

about

Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study.High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series

P2860

Q35956711-6D7936AE-60E0-4190-BE20-2365E1DAF79E Q36224399-08DD464E-9089-4A06-9B82-A12D1AC82C19

P2860

New therapeutic targets in the management of urothelial carcinoma of the bladder

Item

http://www.wikidata.org/entity/Q37305943

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New therapeutic targets in the management of urothelial carcinoma of the bladder

@en

New therapeutic targets in the management of urothelial carcinoma of the bladder.

@nl

type

Item

label

New therapeutic targets in the management of urothelial carcinoma of the bladder

@en

New therapeutic targets in the management of urothelial carcinoma of the bladder.

@nl

prefLabel

New therapeutic targets in the management of urothelial carcinoma of the bladder

@en

New therapeutic targets in the management of urothelial carcinoma of the bladder.

@nl

P1476

New therapeutic targets in the management of urothelial carcinoma of the bladder

@en

P2093

Einar F Sverrisson

http://www.w3.org/2001/XMLSchema#string

Patrick N Espiritu

http://www.w3.org/2001/XMLSchema#string

Philippe E Spiess

http://www.w3.org/2001/XMLSchema#string

P2860

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

The PI3K pathway as drug target in human cancer

Cancer treatment and survivorship statistics, 2012

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.

P304

53-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/RRU.S29131

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259628543

http://www.w3.org/2001/XMLSchema#string

P698

24400235

http://www.w3.org/2001/XMLSchema#string

P932

3826897

http://www.w3.org/2001/XMLSchema#string

New therapeutic targets in the management of urothelial carcinoma of the bladder

about

P2860

P2860

New therapeutic targets in the management of urothelial carcinoma of the bladder

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932